Evaluation of Usefulness of Radio-iodine SPECT/CT in Differentiated Thyroid Cancer
![]() |
Lee, Jeong-Won
(Hospital and Research Institute, National Cancer Center)
Lee, Ho-Young (Hospital and Research Institute, National Cancer Center) Oh, So-Won (Hospital and Research Institute, National Cancer Center) Kim, Seok-Ki (Hospital and Research Institute, National Cancer Center) Jeong, Ki-Wook (Hospital and Research Institute, National Cancer Center) Kim, Seon-Wook (Hospital and Research Institute, National Cancer Center) Kang, Keon-Wook (Hospital and Research Institute, National Cancer Center) |
1 | Unal S, Menda Y, Adalet I. Boztepe H, Ozbey N, Alagol F, et al. Thallium-201, technetium-99m-tetrofosmin and iodine-131 in detecting differentiated thyroid carcinoma metastases. J Nucl Med 1998;39:1897-902 |
2 | Intenzo CM, Jabbour S, Dam HQ, Capuzzi DM. Changing concepts in the management of differentiated thyroid cancer. Semin Nucl Med 2005;35:257-65 DOI ScienceOn |
3 | Tharp K, Israel O, Hausmann J, Bettman L, Martin WH, Daitzchman M et al. Impact of I-131 SPECT/CT images obtained with an integrated system in the follow-up of patients with thyroid carcinoma. Eur J Nucl Med Mol Imaging 2004;31:1435-42 |
4 | Townsend DW, Cherry SR. Combining anatomy and function: the path to true image fusion. Eur Radiol 2001;31:191-205 |
5 | Yamamoto Y, Nishiyama Y, Monden T, Matsumura Y, Satoh K, Ohkawa M. Clinical usefulness of fusion of I-131 SPECT and CT images in patients with differentiated thyroid carcinoma. J Nucl Med 2003;44:1905-10 |
6 | Bryan RH, Furio P, Christoph R, Martin S, Paul WL, Steven IS, et al. A comparison of recombinant human thyrotropin and thyroid hormone withdrawal for the detection of thyroid remnant or cancer. J Clin Endocrinol Metab 1999;84:3877-85 DOI |
7 | Amthauer H, Denecke T, Rohlfing T, Ruf J, Bohmig M, Gutberlet M, et al. Value of image fusion using single photon emission computed tomography with integrated low dose computed tomography in comparison with a retrospective voxel-based method in neuroendocrine tumours. Eur Radiol 2005; 15: 1456-62 DOI |
8 | Ministry of health and welfare. 2002 Annual report of the Korea central cancer registry (2003) |
9 | Pfannenberg AC, Eschmann SM, Horger M, Lamberts R, Vonthein R, Claussen CD, et al. Benefit of anatomical-functional image fusion in the diagnostic work-up of neuroendocrine neoplasm. Eur J Nucl Med Mol Imaging 2003;30:835-43 DOI ScienceOn |
10 | Anderson GS, Fish S, Nakhoda K, Zhuang H, Alavi A, Madel SJ. Comparison of I-123 and I-131 for whole-body imaging after stimulation by recombinant human thyrotropin: a preliminary report. Clin Nucl Med 2003; 28(2): 93-6 DOI |
11 | Weber T, Schilling T, Buchler MW. Thyroid carcinoma. Curr Opin Oncol 2006;18:30-5 |
12 | Mitchell G, Pratt BE, Vini L, McCready VR, Harmer CL. False positive I-131 whole body scans in thyroid cancer. Br J Radiol 2000;73:627-35 DOI |
13 | Even-sapir E, Keidar Z, Sachs J, Engel A, Bettman L, Gaitini D, et al. The new technology of combined transmission and emission tomography in evaluation of endocrine neoplasm. J Nucl Med 2001;42:998-1004 |
14 | Mazzaferri EL, Kloos RT. Current approaches to primary therapy for papillary and follicular thyroid cancer. J Clin Endocrinol Metab 2001;86:1447-63 DOI |
15 | Sherman S. Thyroid carcinoma. Lancet 2003;361:501-11 DOI ScienceOn |
16 | Ruf J, Lehmkuhl L, Bertram H, Sandrock D, Amthauer H, Humplik B, et al. Impact of SPECT and integrated low-dose CT after radioiodine therapy on the management of patients with thyroid carcinoma. Nucl Med Commun 2004;25:1177-82 DOI ScienceOn |
17 | Lupoli GA, Fonderico F, Colarusso S, Panico A, Cavallo A, Micco L et al. Current management of differentiated thyroid carcinoma. Med Sci Monit 2005;11:368-73 |
18 | Shapiro B, Rufini V, Jarwan A, Geatti O, Kearfott KJ, Fig LM, et al. Artifacts, anatomical and physiologic variants, and unrelated disease that might cause false-positive whole-body 131-I scans in patients with thyroid cancer. Semin Nucl Med 2000;30:115-32 DOI ScienceOn |
19 | Sawka AM, Thephamongkhol K, Brouwers M, Thabane L, Browman G, Gerstein HC. A systemic review and metaanalysis of the effectiveness of radioactive iodine remnant ablation for well-differentiated thyroid cancer. J Clin Endocrinol Metab 2004;89:3668-76 DOI |
20 | Robbins RJ, Chon JT, Fleisher M, Larson SM, Tuttle RM. Is the serum thyroglobulin response to recombinant human thyrotropin sufficient, by itself, to monitor for residual thyroid carcinoma. J Clin Endocrinol Metab 2002;87:3242-47 DOI |
21 | Edwa rds BK, Howe HL, Ries, LA, Thun MJ, Rosenberg HM, Yancik R, et al. Annual report to the nation on the status of cancer, 1973.1999, featuring implications of age and aging on U.S. cancer burden. Cancer 2002:94; 2766-92 DOI ScienceOn |
22 | Mandel SJ, Shankar LK, Benard F, Yamamoto A, Alavi A. Superiority of iodine-123 compared with iodine-131 scanning for thyroid remnants in patients with differentiated thyroid cancer. Clin Nucl Med 2001; 26(1): 6-9 DOI ScienceOn |
![]() |